Depression at 39th ECNP Congress
5 sessions on depression · October 10–13, 2026, Munich, Germany. Compare depression at other meetings →
Saturday, October 10
Symposium
S03 – Breaking Hot Topic Symposium – showcasing the timeliest science – Altered immune function in psychiatric disorders and their treatment
Boris B. Quednow · Sinead King · Jenny Borkent · Anthony Vernon · Cynthia Fu
Late-breaking findings on immune dysfunction in psychiatry, including the MEMOCYCLINE trial, microbiome-guided treatment, and immune-ageing phenotypes of depression.
Inflammation & Immunopsychiatry · Drug Pipeline & Clinical Trials
Sunday, October 11
Symposium
S08 – Speech, digital phenotyping, and artificial intelligence in understanding and predicting trajectories and upcoming episodes in affective disorders
Dominic Oliver · Vera Ludwig · Srinivasan Vairavan · Maria Faurholt-Jepsen
NLP on health records, smartphone-based phenotyping, and machine learning to predict mood episodes and classify affective disorders.
Symposium
MS01 – Mini Symposium – Amyloid- and tau-PET biomarkers in late life depression: an update
Willemijn Jansen · Mathieu Vandenbulcke
PET biomarkers of amyloid, tau, and synaptic density in geriatric depression, including the Leuven L3D study.
Dementia & Cognitive Disorders · Geriatric · Neuroscience & Mechanisms
Symposium
MS02 – Proof-of-concept studies showcasing biomarker potential
Leanne Williams · Daniel Gehrlach
Stratified precision-medicine trials, including an alpha-2a agonist for the cognitive biotype of depression and phase 2 results for the vasopressin 1b antagonist nelivaptan.
Pharmacogenomics & Precision Psychiatry · Drug Pipeline & Clinical Trials
Monday, October 12
Symposium
S12 – New Findings Symposium
A. Coen Coomans · Bengisu Aksoy · Maja Friedemann · Edoardo Pisa · Minh Nguyen · Laura Costantini
Six short talks on brand-new findings, from personalized rTMS targets in OCD to glymphatic function in depression and transcranial ultrasound stimulation.
Other topics at this meeting
Neuroscience & Mechanisms 23Drug Pipeline & Clinical Trials 8Digital Psychiatry & AI 7Pharmacogenomics & Precision Psychiatry 7Inflammation & Immunopsychiatry 6Schizophrenia & Psychosis 6Child & Adolescent 5Autism & Neurodevelopmental Disorders 4Neuromodulation (ECT, TMS) 4OCD & Related Disorders 4ADHD 3Practice, Policy & Workforce 3